MOG and experimental autoimmune encephalomyelitis: IL-17A was reported to modulate the severity of myelin oligodendrocyte glycoprotein (MOG)-induced experimental autoimmune encephalomyelitis (EAE), although the magnitude of this effect varies substantially between studies35–37.